These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10406018)

  • 1. Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes.
    Bijak M
    Neurosci Lett; 1999 Jun; 268(3):115-8. PubMed ID: 10406018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro.
    Klapstein GJ; Colmers WF
    J Neurophysiol; 1997 Sep; 78(3):1651-61. PubMed ID: 9310450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
    El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
    Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
    Abounader R; Villemure JG; Hamel E
    Br J Pharmacol; 1995 Oct; 116(4):2245-50. PubMed ID: 8564255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic actions of neuropeptide Y in the mouse hippocampus require Y5 receptors.
    Baraban SC
    Epilepsia; 2002; 43 Suppl 5():9-13. PubMed ID: 12121287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
    Monnet FP; Fournier A; Debonnel G; de Montigny C
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1212-8. PubMed ID: 1469629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
    Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
    Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain.
    Widdowson PS
    Brain Res; 1993 Dec; 631(1):27-38. PubMed ID: 8298993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices.
    Ho MW; Beck-Sickinger AG; Colmers WF
    J Neurophysiol; 2000 Feb; 83(2):723-34. PubMed ID: 10669488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS; Buckingham R; Williams G
    Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro.
    Greber S; Schwarzer C; Sperk G
    Br J Pharmacol; 1994 Nov; 113(3):737-40. PubMed ID: 7858862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
    You J; Edvinsson L; Bryan RM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
    Haynes JM; Hill SJ; Selbie LA
    Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
    Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
    Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.
    Fu LY; Acuna-Goycolea C; van den Pol AN
    J Neurosci; 2004 Oct; 24(40):8741-51. PubMed ID: 15470140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.